SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Ampio Pharmaceuticals, Inc. Reports Pre-IND Meeting With the FDA to Obtain Clinical Path Guidance for Ampion™ for the Treatment of Chronic Pain of Osteoarthritis of the Knee and Schedules May 16th Webcast to Update Shareholders